WallStreetZenWallStreetZen

NASDAQ: ACOG
Alpha Cognition Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ACOG

Based on 1 analyst offering 12 month price targets for Alpha Cognition Inc

Min Forecast
$18.00+271.9%
Avg Forecast
$18.00+271.9%
Max Forecast
$18.00+271.9%

Should I buy or sell ACOG stock?

Based on 1 analyst offering ratings for Alpha Cognition Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ACOG's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates ACOG as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ACOG stock forecasts and price targets.

ACOG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-19

1 of 1

Forecast return on equity

Is ACOG forecast to generate an efficient return?

Company
N/A
Industry
352.12%
Market
211.34%

Forecast return on assets

Is ACOG forecast to generate an efficient return on assets?

Company
N/A
Industry
122.26%

ACOG earnings per share forecast

What is ACOG's earnings per share in the next 1 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.35

ACOG revenue forecast

What is ACOG's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$25.1M+238.58%
Avg 2 year Forecast
$57.3M+671.08%
Avg 3 year Forecast
$140.1M+1,786.18%
ACOG's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ACOG revenue growth forecast

How is ACOG forecast to perform vs Biotechnology companies and vs the US market?

Company
160.49%
Industry
116.92%
Market
23.08%
ACOG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ACOG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ACOG vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACOG$4.84$18.00+271.90%Buy
CBUS$1.95$15.00+669.23%Strong Buy
ONCY$0.98$8.50+766.46%Strong Buy
SEER$1.82N/AN/A
CSBR$7.31N/AN/A
View Top Biotech Stocks

Alpha Cognition Stock Forecast FAQ

Is Alpha Cognition Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ACOG) stock is to Buy ACOG stock.

Out of 1 analyst, 0 (0%) are recommending ACOG as a Strong Buy, 1 (100%) are recommending ACOG as a Buy, 0 (0%) are recommending ACOG as a Hold, 0 (0%) are recommending ACOG as a Sell, and 0 (0%) are recommending ACOG as a Strong Sell.

If you're new to stock investing, here's how to buy Alpha Cognition stock.

What is ACOG's earnings growth forecast for 2026-2026?

(NASDAQ: ACOG) Alpha Cognition's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.84%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.88%.

Alpha Cognition's earnings in 2026 is -$19,472,305.

In 2026, ACOG is forecast to generate -$29,384,454 in earnings, with the lowest earnings forecast at -$32,600,111 and the highest earnings forecast at -$25,568,714.

What is ACOG's revenue growth forecast for 2026-2028?

(NASDAQ: ACOG) Alpha Cognition's forecast annual revenue growth rate of 160.49% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 116.92%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.08%.

Alpha Cognition's revenue in 2026 is $7,427,199.On average, 4 Wall Street analysts forecast ACOG's revenue for 2026 to be $546,748,689, with the lowest ACOG revenue forecast at $507,112,834, and the highest ACOG revenue forecast at $582,318,771. On average, 3 Wall Street analysts forecast ACOG's revenue for 2027 to be $1,245,170,296, with the lowest ACOG revenue forecast at $1,196,337,530, and the highest ACOG revenue forecast at $1,281,783,999.

In 2028, ACOG is forecast to generate $3,045,851,349 in revenue, with the lowest revenue forecast at $2,926,487,198 and the highest revenue forecast at $3,135,428,818.

What is ACOG's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ACOG) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 122.26%.

What is ACOG's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ACOG price target, the average ACOG price target is $18.00, with the highest ACOG stock price forecast at $18.00 and the lowest ACOG stock price forecast at $18.00.

The Wall Street analyst predicted that Alpha Cognition's share price could reach $18.00 by Dec 19, 2026. The average Alpha Cognition stock price prediction forecasts a potential upside of 271.9% from the current ACOG share price of $4.84.

What is ACOG's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: ACOG) Alpha Cognition's current Earnings Per Share (EPS) is -$1.37. In 2026, ACOG's EPS is forecast to hit -$1.35 (min: -$1.50, max: -$1.18).

What is ACOG's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ACOG) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.